Form D · Biotechnology
Algorithm Sciences, Inc.
New York, NY · CIK 0001776575
Offering snapshot reported Apr 12, 2024 · SEC filing
- Reported sold
- $350K Offering amount: $23.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 9, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2024 | Initial | $350,000 | No comparison | 2 | SEC filing |
| Apr 7, 2023 | Initial | $684,651 | No comparison | 35 | SEC filing |
| Dec 28, 2021 | Initial | $1,135,000 | No comparison | 10 | SEC filing |
| Mar 26, 2021 | Initial | $2,899,500 | No comparison | 39 | SEC filing |
| Oct 23, 2019 | Initial | $2,087,980 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $420K
- Finders' fees
- $0
- Form D file number
- 021-510464
Assumes maximum commission fees paid.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Laidlaw & Company (UK) Ltd. | 000119037 |
Source: Form D, filed Apr 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Ahern | Director |
| David Cavalier | Executive |
| Matthew Duffy | Director |
| Patrick Gallagher | Director |
| Gary Gemigani | Director |
| Gary Gemignani | Director |
| Kamal Mubarak | Director, Executive |
| Kamal Mubark | Director |
| Jeffrey O'donnell | Director |
| Jeff O'donnell | Director |
| Michael Tilton | Director, Executive |
| Anthony Zook | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
575 5 Th Avenue 14 Th Floor
New York, NY, 10017
New York, NY, 10017